INTELLIGENT BIO SOLUTIONS IN (INBS) Stock Earnings & Estimates
USA - NASDAQ:INBS - US36151G6008 - Common Stock
0.793 USD
-0.01 (-1.72%)
0.7975 USD
+0 (+0.57%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 1.257M 187.49% | 3.112M 147.58% | 3.053M -1.91% | 26.816M 778.49% | |
| EBITDA YoY % growth | -7.622M | -9.309M -22.13% | -9.455M -1.57% | N/A | |
| EBIT YoY % growth | -8.437M -1.19% | -10.283M -21.89% | -10.425M -1.38% | 2.101M 120.15% | |
| Operating Margin | -671.21% | -330.46% | -341.51% | 7.83% | |
| EPS YoY % growth | N/A 51.95% | N/A 95.32% | N/A 65.94% | 0.36 128.00% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 78.14% | 0.04 112.50% | 0.14 150.00% | 0.34 375.00% |
| Revenue Q2Q % growth | 4.916M 463.76% | 5.63M 826.75% | 7.293M 900.55% | 8.966M 962.45% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -958.8K 64.82% | 224.4K 109.91% | 826.2K 132.36% | 1.999M 169.37% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 90.87% | -0.12 | % | |
| Q3 2025 Q2Q % growth | 80.03% | -0.29 | % | |
| Q2 2025 Q2Q % growth | 84.23% | -0.33 | % | |
| Q1 2025 Q2Q % growth | -0.70 -7.23% | -0.54 | -0.16 | -29.49% |
| Q4 2024 Q2Q % growth | -1.34 94.15% | -0.52 | -0.82 | -157.59% |
| Q3 2024 Q2Q % growth | -1.43 94.13% | -0.89 | -0.54 | -61.14% |
| Q2 2024 Q2Q % growth | -2.07 62.50% | -3.30 | 1.23 | 37.36% |
| Q1 2024 Q2Q % growth | -716.00% | -0.65 | % | |
| Q4 2023 Q2Q % growth | -22.92 31.79% | -18.24 | -4.68 | -25.67% |
| Q3 2023 Q2Q % growth | -24.36 -12.78% | -25.34 | 0.98 | 3.86% |
| Q2 2023 Q2Q % growth | -5.52 90.00% | -26.93 | 21.41 | 79.50% |
| Q4 2022 Q2Q % growth | -33.60 | -44.06 | 10.46 | 23.75% |
| Q3 2022 Q2Q % growth | -21.60 | -39.17 | 17.57 | 44.85% |
| Q2 2022 Q2Q % growth | -55.20 | -39.17 | -16.03 | -40.93% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 843.9K 15.92% | 4.376M | -3.532M | -80.72% |
| Q3 2025 Q2Q % growth | 728.9K -11.54% | 3.397M | -2.668M | -78.54% |
| Q2 2025 Q2Q % growth | 607.5K -20.48% | 2.295M | -1.688M | -73.53% |
| Q1 2025 Q2Q % growth | 872K 9.53% | 1.785M | -913K | -51.15% |
| Q4 2024 Q2Q % growth | 728K 64.33% | 1.459M | -731K | -50.10% |
| Q3 2024 Q2Q % growth | 824K 80.31% | 1.214M | -390K | -32.13% |
| Q2 2024 Q2Q % growth | 764K 114.19% | 1.028M | -264K | -25.68% |
| Q1 2024 Q2Q % growth | 796.1K | 969K | -172.9K | -17.84% |
| Q4 2023 Q2Q % growth | 443K 562.18% | 581.91K | -138.91K | -23.87% |
| Q3 2023 Q2Q % growth | 457K 137.40% | 678.3K | -221.3K | -32.63% |
| Q2 2023 Q2Q % growth | 356.7K 100.62% | 693.6K | -336.9K | -48.57% |
| Q4 2022 Q2Q % growth | 66.9K -95.84% | 66.9K | % | |
| Q3 2022 Q2Q % growth | 192.5K 461.22% | 192.5K | % | |
| Q2 2022 Q2Q % growth | 177.8K -37.17% | 177.8K | % | |
| Q1 2022 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |